Melasma
☆ Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
Ieu mangrupakeun kaayaan umum dititénan dina awéwé Asian di 40s mimiti maranéhanana. Lesi bunderan dina poto langkung caket kana lentigo tinimbang melasma.
References
Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
Anyar-anyar ieu, low-fluence Q-switched Nd:YAG (LFQSNY) laser parantos populer pikeun ngubaran melasma, khususna di Asia. Nyimpulkeun rupa-rupa studi éta nangtang, tapi LFQSNY sigana umumna efektif sareng aman pikeun melasma dibandingkeun sareng terapi tradisional. Sanajan kitu, sababaraha kasus hypopigmentation mottled geus dilaporkeun salaku éfék samping LFQSNY, kamungkinan alatan énergi laser tinggi. Pamakéan agrésif LFQSNY ogé tiasa nyababkeun hiperpigmentasi tina peradangan, khususna dina warna kulit anu langkung poék.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Masalah pigmentasi sering kapanggih dina perawatan primér. Jenis umum tina gangguan hyperpigmentation kaasup post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Melasma teu tiasa direngsekeun ku perawatan laser pikeun sababaraha waktos, sabab éta mangrupikeun panyakit dimana pigmén terus diproduksi. Asam tranxenemic ngabantosan ningkatkeun pikeun ngirangan pigmentasi.
○ Perlakuan
Di sababaraha nagara (misalna Jepang, Korea), asam traneksamat oral sayogi di toko sareng mujarab. Krim melasma sareng asam traneksamat sareng asam azelaic tiasa sawaréh ngabantosan.
Hydroquinone tiasa dianggo sacara topikal pikeun pengobatan hiperpigmentasi, tapi FDA ngeureunkeun produk OTC anu ngandung hydroquinone dina taun 2020.
#Tranexamic acid [TRANSINO]
#Laser toning technique (low fluence QS1064 laser)
#Triluma